Last edition
News about
Nxera Pharma to Receive USD 4.6 Million from Centessa
Nxera Pharma has been expecting to receive USD 4.6 million in milestone payments from Centessa Pharmaceuticals under a license agreement regarding Nxera technology used to help design Centessa’s novel orexin receptor 2 (OX2R) agonist, ORX750.
H.E.L Group Expands its Sales Newtowk with Addition of Two Specialist Distributors
H.E.L Group (H.E.L) has expanded its global sales network with the appointment of two distributors: Paralab and ProAnalytics.
Johnson and Johnson to Obtain Rights to Clinical-Stage Bispecific Antibody
Johnson & Johnson has signed a definitive deal with Numab Therapeutics, to acquire from Numab’s shareholders its wholly-owned subsidiary for the global rights to a novel, investigational first-in-class bispecific antibody, NM26.
Merck Announces Acquisition of EyeBio
Merck has signed a definitive agreement under which Merck, through a subsidiary, will acquire EyeBio.
HanAll Biopharma and Turn Bio to Develop Novel Treatments for Eye and Ear Diseases
HanAll Biopharma Co., Ltd. has signed an exclusive licensing deal with Turn Biotechnologies, Inc., a pre-clinical stage biopharmaceutical company focused on cellular repair through epigenetic reprogramming.
Helsinn Signs License Deal with Angelini Pharma to Commercialize AULIN and MESULID
Helsinn Group has signed Distribution and Licence Agreement renewal with Angelini Pharma in Bulgaria, Czech Republic, Hungary, Poland, Romania and Slovak Republic for AULIN and MESULID (Nimesulide) for the treatment of acute (short-term) pain.
Reddy Pharma Iberia and Theranica Launch Nerivio in Spain
Dr. Reddy's Laboratories Ltd. and its subsidiaries have introduced Nerivio in Spain through its step-down subsidiary, Reddy Pharma Iberia S.A.
MilliporeSigma Unveils First Software for Complete Data Traceability in Microbial QC
MilliporeSigma, the US and Canada Life Science business of Merck KGaA, has rolled out its M-Trace Software and Mobile App, a comprehensive data tracking solution to digitize sterility testing.
Gerresheimer Expands Capacities for Medical Systems in USA
Gerresheimer is significantly expanding its production capacities for medical systems such as inhalers and autoinjectors in the United States.
AcariaHealth Opens Modern Specialty Pharmacy Facility in Chesterfield, Missouri
The facility is the home of Foundation Care, one of AcariaHealth's Centers of Excellence devoted to providing personalized care to patients with rare and chronic conditions.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy